Truist analyst Asthika Goonewardene lowered the firm’s price target on BioNTech (BNTX) to $151 from $172 and keeps a Buy rating on the shares.

European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 1.03% to 1,388.44 on the S&P Europe Select ADR Index. From continental Europe, the gainers ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

One of the standouts of today's morning trading session was Interactive Brokers, which logged a 1.5% performance and ...